| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5694626 | European Urology | 2017 | 12 Pages | 
Abstract
												We performed a cumulative analysis of the literature to determine the best treatment option in cases of localized kidney tumor of higher clinical stage (T1b and T2, as based on preoperative imaging). Our findings suggest that removing only the tumor and saving the kidney might be an effective treatment modality in terms of cancer control, with the advantage of preserving the kidney function. However, a higher risk of perioperative complications should be taken into account when facing larger tumors (clinical stage T2) with kidney-sparing surgery.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino, 
											